Gero
Signal active
Organization
Contact Information
Overview
GERO is an AI Drug Discovery company created to solve chronic diseases
About
Industries
Biotechnology, Artificial Intelligence (AI), InsurTech, Pharmaceutical, Genetics
Founded
2015
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
Gero headquartered in Asia, operates in the Biotechnology, Artificial Intelligence (AI), InsurTech, Pharmaceutical, Genetics sector. The company focuses on Biotechnology and has secured $360.0M in funding across 60 round(s). With a team of 11-50 employees, Gero is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Gero, raised $6.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
3
Lead Investors
0
Total Funding Amount
$6.0M
Details
3
Gero has raised a total of $6.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Seed | |||
| 2020 | Early Stage Venture | |||
| 2023 | Early Stage Venture | 6.0M |
Investors
Gero is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Melnichek Investments | - | FUNDING ROUND - Melnichek Investments | 6.0M |
| VitaDAO | - | FUNDING ROUND - VitaDAO | 6.0M |
| Gero | - | FUNDING ROUND - Gero | 6.0M |
| Leo Lozner | - | FUNDING ROUND - Leo Lozner | 6.0M |
Recent Activity
There is no recent news or activity for this profile.